期刊文献+

纤溶酶原激活物抑制物1和器官纤维化 被引量:5

Plasminogen Activator Inhibitor-1 and Organic Fibrosis
暂未订购
导出
摘要 近年来器官纤维化机制的研究热点集中在细胞外基质(ECM)降解过程及其发生机制上。纤溶酶原激活物及其抑制物1(PAI-1)是参与调节ECM代谢的关键酶系,PAI-1的异常表达在器官纤维化的进展过程中起重要作用。现对PAl-1生物学特性以及它和肾纤维化、肺纤维化、肝纤维化、心脏纤维化的关系的研究进展予以综述,为器官纤维化的诊治提供参考。 At present the research on organic fibrosis mainly focuses on the degradation of extracellular matrix and its mechanisms.The system of plasminogen activator and plasminogen activator inhibitor-1 is a key enzyme system involved in adjusting the metabolism of extracellular matrix.The abnormal expression of PAI-1 plays an important role in organic fibrosis.In this review,the characteristics of PAI-1 and the association with organic fibrosis,such as renal fibrosis,pulmonary fibrosis,hepatic fibrosis and cardiac fibrosis were summarized to direct the diagnosis and therapy of organic fibrosis.
出处 《医学综述》 2010年第9期1308-1310,共3页 Medical Recapitulate
关键词 纤溶酶原激活物抑制物1 转化生长因子 纤维化 Plasminogen activator inhibitor-1 Transforming growth factor Fibrosis
  • 相关文献

参考文献3

二级参考文献36

  • 1张春,孟宪芳,朱忠华,杨晓,邓安国.Role of connective growth factor in plasminogen activator inhibitor-1 and fibronectin expression induced by transforming growth factor β1 in renal tubular cells[J].Chinese Medical Journal,2004(7):990-996. 被引量:20
  • 2陈洁,王建安,骆荣华,胡新央,谢小洁,李佳慧,何爱娜,孙勇.骨髓间充质干细胞移植对大鼠心肌梗死后心室重构的影响[J].中华急诊医学杂志,2006,15(4):310-314. 被引量:10
  • 3Liu Y. Renal fibrosis:New insight into the pathogenesis and therapeutics, Kidney international,2006,213-217.
  • 4Hirschberg R. Wound healing in the kidney:complex interactions in renal interstial fibrogenesis. J Am Soc Nephrol,2005 ,16 :9 - 11.
  • 5Eddy AA. Molecular basis of renal fibrosis. Pediar Nephrol,2000,15:290 -301.
  • 6Liu Y. Epithelial to mesenchymal transition in renal fobrosis:Pathologic significance ,molecular mechanism,and therapeutic intervation. J Am Soc Nephrol,2004,15 : 1 - 12.
  • 7Bottinger EP,Bitzer M. TGF-beta signaling in renal disease. J Am Soc Nephrol,2002,13 :2600 - 2610.
  • 8Schnaper HW,Hayashida T,Hubchak SC et al. TGF- beta signal transduction and mesangial cell fibrosis. Am J Physiol Renal Physiol, 2003, 284 :F243 - F252.
  • 9Liu Y. Hepatocyte growth factor in kidney fibrosis:therapeutic potential and mechanisms of action. Am J Physiol Renal Physiol,2004,287:F7 - F16.
  • 10Yang J,Dai C,Liu Y. Hepatocyte growth factor gene therapy and angiotensin Ⅱ brockade synergistically attenuate renal interstitial fibrosis in mice. J Am Soc Nephrol ,2002 ,13 ,2464 -2477.

共引文献32

同被引文献60

引证文献5

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部